Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]

Precision medicine was born with the development of new diagnostic techniques and targeted drugs, yielding better outcomes in cancer care. With the evolution and increasing sensitivity for detecting oncogenic drivers, liquid biopsies (LBs), specifically cell-free DNA (cfDNA) analysis, have been prop...

Full description

Autores:
Rolfo, Christian
Cardona-Mendoza, Andrés Felipe
Cristofanilli, Massimo
Paz-Ares, Luis
Díaz-Mochõn, Juan José
Durán, Ignacio
Raez, Luis Estuardo
Russo, Alessandro
LORENTE, JOSE A.
Malapelle, Umberto
Gil-Bazo, Ignacio
Jantus Lewintre, Eloisa
Pauwels, Patrick
Mok, Tony
Serrano, María José
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/3907
Acceso en línea:
http://hdl.handle.net/20.500.12495/3907
https://doi.org/10.1016/j.critrevonc.2020.103058
https://repositorio.unbosque.edu.co
Palabra clave:
Liquid biopsy
Cell-free DNA
Perspective
ISLB
NGS
Precision oncology
Rights
openAccess
License
Acceso abierto
id UNBOSQUE2_3a490e6479fad41e48a2cd136c9bb3fb
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/3907
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
dc.title.translated.spa.fl_str_mv Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
title Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
spellingShingle Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
Liquid biopsy
Cell-free DNA
Perspective
ISLB
NGS
Precision oncology
title_short Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
title_full Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
title_fullStr Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
title_full_unstemmed Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
title_sort Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]
dc.creator.fl_str_mv Rolfo, Christian
Cardona-Mendoza, Andrés Felipe
Cristofanilli, Massimo
Paz-Ares, Luis
Díaz-Mochõn, Juan José
Durán, Ignacio
Raez, Luis Estuardo
Russo, Alessandro
LORENTE, JOSE A.
Malapelle, Umberto
Gil-Bazo, Ignacio
Jantus Lewintre, Eloisa
Pauwels, Patrick
Mok, Tony
Serrano, María José
dc.contributor.author.none.fl_str_mv Rolfo, Christian
Cardona-Mendoza, Andrés Felipe
Cristofanilli, Massimo
Paz-Ares, Luis
Díaz-Mochõn, Juan José
Durán, Ignacio
Raez, Luis Estuardo
Russo, Alessandro
LORENTE, JOSE A.
Malapelle, Umberto
Gil-Bazo, Ignacio
Jantus Lewintre, Eloisa
Pauwels, Patrick
Mok, Tony
Serrano, María José
dc.contributor.orcid.none.fl_str_mv Cardona-Mendoza, Andrés Felipe [0000-0002-6697-5471]
dc.subject.keywords.spa.fl_str_mv Liquid biopsy
Cell-free DNA
Perspective
ISLB
NGS
Precision oncology
topic Liquid biopsy
Cell-free DNA
Perspective
ISLB
NGS
Precision oncology
description Precision medicine was born with the development of new diagnostic techniques and targeted drugs, yielding better outcomes in cancer care. With the evolution and increasing sensitivity for detecting oncogenic drivers, liquid biopsies (LBs), specifically cell-free DNA (cfDNA) analysis, have been proposed as a minimally-invasive technique for genomic profiling. Ranging from sequencing techniques to PCR-based methods and other more complex strategies, this approach, currently applicable in some solid tumors with robust evidence, is showing promising opportunities in other cancers. However, difficulties in validating their clinical utility exist within limitation at different levels among several techniques, reporting of the results, lack of appropriate clinical trial designs, and unknown economic impact. One of the aims of the ISLB is to create recommendations to develop reliable and sustainable diagnostic, prognostic and predictive tools using LBs. This paper is addressing these objectives, helping the healthcare providers and scientific community to understand the potential of LB.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-09-01T20:13:27Z
dc.date.available.none.fl_str_mv 2020-09-01T20:13:27Z
dc.date.issued.none.fl_str_mv 2020
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1040-8428
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/3907
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.critrevonc.2020.103058
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv https://repositorio.unbosque.edu.co
identifier_str_mv 1040-8428
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
url http://hdl.handle.net/20.500.12495/3907
https://doi.org/10.1016/j.critrevonc.2020.103058
https://repositorio.unbosque.edu.co
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv Critical Reviews in Oncology/Hematology, 1040-8428, Vol. 154, 2020
dc.relation.uri.none.fl_str_mv https://www.sciencedirect.com/science/article/abs/pii/S1040842820301165?via%3Dihub
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2020-07-07
rights_invalid_str_mv Acceso abierto
http://purl.org/coar/access_right/c_abf2
2020-07-07
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.journal.spa.fl_str_mv Critical Reviews in Oncology/Hematology
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/0beb0362-a577-4ae4-8906-a8cdb2320c0f/download
https://repositorio.unbosque.edu.co/bitstreams/24908a09-0c34-4aff-99a7-fa9e7b74a5ea/download
https://repositorio.unbosque.edu.co/bitstreams/26a30262-d08d-4911-8dc4-5aaba502a9fe/download
https://repositorio.unbosque.edu.co/bitstreams/a376ea7e-356a-4270-ad35-4ed8a60750ef/download
bitstream.checksum.fl_str_mv 7210a811635d1799e7c05fee5d259be7
be4d6e97f6c804fc21048b9cc0b17b98
8a4605be74aa9ea9d79846c1fba20a33
e1ff5d7979da3ee8bedfb266024acd05
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1814100724883128320
spelling Rolfo, ChristianCardona-Mendoza, Andrés FelipeCristofanilli, MassimoPaz-Ares, LuisDíaz-Mochõn, Juan JoséDurán, IgnacioRaez, Luis EstuardoRusso, AlessandroLORENTE, JOSE A.Malapelle, UmbertoGil-Bazo, IgnacioJantus Lewintre, EloisaPauwels, PatrickMok, TonySerrano, María JoséCardona-Mendoza, Andrés Felipe [0000-0002-6697-5471]2020-09-01T20:13:27Z2020-09-01T20:13:27Z20201040-8428http://hdl.handle.net/20.500.12495/3907https://doi.org/10.1016/j.critrevonc.2020.103058instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquehttps://repositorio.unbosque.edu.coapplication/pdfengElsevierCritical Reviews in Oncology/HematologyCritical Reviews in Oncology/Hematology, 1040-8428, Vol. 154, 2020https://www.sciencedirect.com/science/article/abs/pii/S1040842820301165?via%3DihubCorrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]Corrigendum to“Challenges and opportunities of cfDNA analysisimplementation in clinical practice: Perspective of the International Societyof Liquid Biopsy (ISLB)”[Crit. Rev. Oncol. Hematol. 151 (July) (2020)102978]Artículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Liquid biopsyCell-free DNAPerspectiveISLBNGSPrecision oncologyPrecision medicine was born with the development of new diagnostic techniques and targeted drugs, yielding better outcomes in cancer care. With the evolution and increasing sensitivity for detecting oncogenic drivers, liquid biopsies (LBs), specifically cell-free DNA (cfDNA) analysis, have been proposed as a minimally-invasive technique for genomic profiling. Ranging from sequencing techniques to PCR-based methods and other more complex strategies, this approach, currently applicable in some solid tumors with robust evidence, is showing promising opportunities in other cancers. However, difficulties in validating their clinical utility exist within limitation at different levels among several techniques, reporting of the results, lack of appropriate clinical trial designs, and unknown economic impact. One of the aims of the ISLB is to create recommendations to develop reliable and sustainable diagnostic, prognostic and predictive tools using LBs. This paper is addressing these objectives, helping the healthcare providers and scientific community to understand the potential of LB.Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2020-07-07THUMBNAILChristian Rolfoa, Andrés F. Cardona_2020.pdf.jpgChristian Rolfoa, Andrés F. Cardona_2020.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/0beb0362-a577-4ae4-8906-a8cdb2320c0f/download7210a811635d1799e7c05fee5d259be7MD53ORIGINALChristian Rolfoa, Andrés F. Cardona_2020.pdfChristian Rolfoa, Andrés F. Cardona_2020.pdfapplication/pdf139941https://repositorio.unbosque.edu.co/bitstreams/24908a09-0c34-4aff-99a7-fa9e7b74a5ea/downloadbe4d6e97f6c804fc21048b9cc0b17b98MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/26a30262-d08d-4911-8dc4-5aaba502a9fe/download8a4605be74aa9ea9d79846c1fba20a33MD52TEXTChristian Rolfoa, Andrés F. Cardona_2020.pdf.txtChristian Rolfoa, Andrés F. Cardona_2020.pdf.txtExtracted texttext/plain5330https://repositorio.unbosque.edu.co/bitstreams/a376ea7e-356a-4270-ad35-4ed8a60750ef/downloade1ff5d7979da3ee8bedfb266024acd05MD5420.500.12495/3907oai:repositorio.unbosque.edu.co:20.500.12495/39072024-02-07 00:45:51.723restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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